IRMD Stock Analysis: Buy, Sell, or Hold?
IRMD - iRadimed Corporation
$100.97
2.93 (2.99%)
▲
5d:
+7.56%
30d:
+12.36%
90d:
+4.59%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 07, 2026
Get Alerted When IRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IRMD is fairly valued with market pricing in 0.6% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: IRMD is fairly valued with market pricing in 0.6% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$89.34
Based on 8.8% avg growth
INTRINSIC VALUE TODAY
$55.47
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRMD is currently trading at $100.97, which is considered extended relative to its 30-day fair value range of $91.07 to $95.97. The stock's valuation (Forward PE: 42.9) is in line with its historical norms (42.1). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, IRMD is in a downtrend. The price is approaching resistance at $101.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IRMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $118.00 (+16.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IRMD is in a downtrend. The price is approaching resistance at $101.13. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IRMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $118.00 (+16.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$91.07 -
$95.97
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.7%
Protect Your Profits
IRMD is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.2% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($118.00)
- NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$91.07 -
$95.97
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$90.18
Resistance Level
$101.13
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
42.87
Wall Street Target
$118.00
(+16.9%)
Revenue Growth (YoY)
12.6%
Earnings Growth (YoY)
22.1%
Profit Margin
27.4%
Valuation Premium vs History
+0.6% premium
PE vs Historical
42.9 vs 42.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$101.58
(+1%)
2-Year Target
$102.19
(+1%)
3-Year Target
$102.80
(+2%)
3-Yr Target (if PE normalizes)
(PE: 43→42)
PE COMPRESSION
$100.94
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 42.9, Growth: 13.5%)
$147.61
(+46%)
Base:
(SPY PE: 21.8, Growth: 13.5%)
$74.98
(-26%)
Bear:
(PE: 18.5, Growth: 13.5%)
$63.74
(-37%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (54x PE), but valuation improves significantly next year (43x PE) as earnings recover.
Trailing PE: 53.57 | Current EPS (TTM): $1.83
Bull Case
$138.78
(+37%)
Analyst growth 28.7%, PE expands to 58.9
Base Case
$126.17
(+25%)
Market implied 28.7%, PE stable at 53.6
Bear Case
$66.67
(-34%)
Severe decline -20.0%, PE contracts to 45.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 8:29 PM ET
Data refreshes hourly during market hours. Next update: 9:29 PM
Data refreshes hourly during market hours. Next update: 9:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Roger E Susi
SELL
2500 shares
2026-04-21
Roger E Susi
SELL
5000 shares
2026-04-20
Roger E Susi
SELL
2500 shares
2026-04-14
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
Advanced IRMD Option Strategies
Professional options setups generated by AI based on today's IRMD price and gamma walls.
